| Identification | |
| Name: | Buserelin |
| Synonyms: | Luteinizinghormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-;1-9-(D-Ser(t-butyl))6-LH-releasing hormone ethylamide;Etilamide;Receptal;Suprefact;[D-Ser(tert-butyl)6,des-Gly-NH210]-LH-RH ethylamide;[D-Ser6(t-Bu),de-Gly10-NH2]-LH-RH ethylamide;? Buserelin; |
| CAS: | 57982-77-1 |
| EINECS: | 261-061-9 |
| Molecular Formula: | C60H86N16O13 |
| Molecular Weight: | 1239.62 |
| InChI: | InChI=1/C60H86N16O13/c1-7-64-57(87)48-15-11-23-76(48)58(88)41(14-10-22-65-59(61)62)69-51(81)42(24-33(2)3)70-56(86)47(31-89-60(4,5)6)75-52(82)43(25-34-16-18-37(78)19-17-34)71-55(85)46(30-77)74-53(83)44(26-35-28-66-39-13-9-8-12-38(35)39)72-54(84)45(27-36-29-63-32-67-36)73-50(80)40-20-21-49(79)68-40/h8-9,12-13,16-19,28-29,32-33,40-48,66,77-78H,7,10-11,14-15,20-27,30-31H2,1-6H3,(H,63,67)(H,64,87)(H,68,79)(H,69,81)(H,70,86)(H,71,85)(H,72,84)(H,73,80)(H,74,83)(H,75,82)(H4,61,62,65)/t40-,41-,42-,43-,44-,45-,46-,47+,48-/m0/s1 |
| Molecular Structure: | ![(C60H86N16O13) Luteinizinghormone-releasing factor (pig), 6-[O-(1,1-dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinami...](https://img1.guidechem.com/chem/e/dict/39/57982-77-1.jpg) |
| Properties | |
| Density: | 1.43 g/cmsup>3 |
| Refractive index: | 1.671 |
| Appearance: | COA |
| Specification: |
? Buserelin , with CAS number of 57982-77-1, can be called (d-ser(bu(supt)(sup6)))-lh-rh(1-9)nonapeptide-ethylamide;(d-ser(tbu)(sup6)-ea(sup10))-lhrh;(d-ser(tbu)(sup6)-ea(sup10))-luteinizinghormone-releasinghormon ; d-ser(tbu(sup6))-lh-rh-(1-9)-nonapeptideethylamide ; d-ser-(tbu)(sup6)-lhrh-ethylamide ; (d-ser(tbu)(sup6)-ea(sup10))-luteinizinghormone-releasinghormone ; etilamide .?Buserelin (CAS NO.57982-77-1) is normally delivered via a nasal spray but is also available as an injection. Buserelin acetate is marketed by Sanofi-Aventis under the brand name Suprefact and a generic form of Buserelin is now produced by CinnaGen under the brand name CinnaFact. |
| Safety Data | |
 |
|
